APG-103

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameAPG-103
Drug Alias NameCD95 receptor inhibitor (Apogenix)APG-103
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionApoptosis-mediating surface antigen FAS inhibitors
TargetsApoptosis-mediating surface antigen FAS
Therapy Area/IndicationsInflammation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesApogenix Gmbh
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesApogenix Gmbh
Active IndicationsN/A
Inactive IndicationsInflammation

Other Information

ATC CodeN/A
Related LinksN/A